Raymond and Beverly Sackler Distinguished Lecture in the Medical Sciences

The Sackler Distinguished Lecture series was established through a generous endowment given by Raymond and Beverly Sackler to the Academy of Medical Sciences in 2003.

The lecture provides a platform for internationally renowned speakers from the medical sciences and promotes debate, discussion and the exchange of ideas on current research. 

Raymond and Beverly Sackler are international philanthropists with a deep longstanding commitment to supporting scientific research. The Sacklers have been dedicated sponsors of basic biomedical research as well as many other areas of intellectual pursuit.  Dr. Sackler is a graduate of New York University and received his doctor of medicine degree from the Middlesex School of Medicine.

Previous speakers

2016  Professor Elaine Fuchs,  Rockefeller University
2015  Professor Stephen Jackson FRS FMedSci,  WT/CRUK Gurdon Institute, University of               Cambridge
2014  Professor Dario Alessi FRS FRSE FMedSci, University of Dundee 
2013  Dr Richard Lifton, Yale University
2012  Professor Linda Partridge CBE FRSE FRS FMedSci, Institute for Healthy Ageing
2011  Dr Venki Ramakrishnan FRS FMedSci, MRC Laboratory of Molecular Biology
2010  Professor Sir David Baulcombe FRS FMedSci, University of Cambridge
2009  Professor Elizabeth Blackburn FRS, University of California, San Francisco
2008  Professor Peter St George-Hyslop FRS, University of Cambridge
2007  Professor Ron Evans, Salk Institute for Biological Studies
2006  Sir Michael J. Berridge FRS FMedSci, Babraham Institute, Cambridge
2005  Sir Aaron Klug OM FRS HonFMedSci, Nobel Laureate
2004  Dr. Joshua Lederberg, Nobel Laureate
2003  Professor Marc Tessier-Lavigne FRS FMedSci, Genentech

2012:The Science of Ageing, by Professor Linda Partridge FMedSci


2013: Disruptions on the highways of cell communications, by Professor Dario Alessi FMedSci


Horizon scanning workshop - Birmingham

Book Now

Horizon scanning workshop - Leeds

Book Now

Bridging the preclinical-clinical boundary: How can we ensure that the UK remains at the forefront of discovering and developing medicines?

Book Now
View more